Economic Evaluations of Cabazitaxel for Treatment of Post-Docetaxel Metastatic Castration-Resistant Prostate Cancer: Evidence From a Systematic Review
Journal of Pharmaceutical Research International
doi 10.9734/jpri/2019/v31i630324
Full Text
Open PDFAbstract
Available in full text
Date
November 27, 2019
Authors
Publisher
Sciencedomain International